POLYRIZON LTD (PLRZ) Fundamental Analysis & Valuation

NASDAQ:PLRZ • IL0011814113

Current stock price

10.94 USD
-0.2 (-1.8%)
Last:

This PLRZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PLRZ Profitability Analysis

1.1 Basic Checks

  • In the past year PLRZ has reported negative net income.
  • In the past year PLRZ has reported a negative cash flow from operations.
  • In the past 5 years PLRZ always reported negative net income.
  • In the past 5 years PLRZ always reported negative operating cash flow.
PLRZ Yearly Net Income VS EBIT VS OCF VS FCFPLRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -1M -2M -3M -4M -5M

1.2 Ratios

  • PLRZ has a Return On Assets of -16.38%. This is in the better half of the industry: PLRZ outperforms 77.33% of its industry peers.
  • Looking at the Return On Equity, with a value of -16.73%, PLRZ belongs to the top of the industry, outperforming 83.14% of the companies in the same industry.
Industry RankSector Rank
ROA -16.38%
ROE -16.73%
ROIC N/A
ROA(3y)-54.72%
ROA(5y)-83.68%
ROE(3y)-406.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLRZ Yearly ROA, ROE, ROICPLRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5K 10K 15K 20K

1.3 Margins

  • PLRZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLRZ Yearly Profit, Operating, Gross MarginsPLRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PLRZ Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PLRZ has more shares outstanding
  • PLRZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PLRZ Yearly Shares OutstandingPLRZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 500K 1M 1.5M
PLRZ Yearly Total Debt VS Total AssetsPLRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 23.32 indicates that PLRZ is not in any danger for bankruptcy at the moment.
  • PLRZ has a better Altman-Z score (23.32) than 89.53% of its industry peers.
  • There is no outstanding debt for PLRZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.32
ROIC/WACCN/A
WACCN/A
PLRZ Yearly LT Debt VS Equity VS FCFPLRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 29.03 indicates that PLRZ has no problem at all paying its short term obligations.
  • PLRZ has a Current ratio of 29.03. This is amongst the best in the industry. PLRZ outperforms 97.67% of its industry peers.
  • PLRZ has a Quick Ratio of 29.03. This indicates that PLRZ is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 29.03, PLRZ belongs to the best of the industry, outperforming 97.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 29.03
Quick Ratio 29.03
PLRZ Yearly Current Assets VS Current LiabilitesPLRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PLRZ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 99.45% over the past year.
EPS 1Y (TTM)99.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. PLRZ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PLRZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLRZ Price Earnings VS Forward Price EarningsPLRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLRZ Per share dataPLRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PLRZ Dividend Analysis

5.1 Amount

  • PLRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLRZ Fundamentals: All Metrics, Ratios and Statistics

POLYRIZON LTD

NASDAQ:PLRZ (4/16/2026, 8:00:01 PM)

10.94

-0.2 (-1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.93%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner Change-14.43%
Market Cap17.72M
Revenue(TTM)N/A
Net Income(TTM)-3.51M
AnalystsN/A
Price TargetN/A
Short Float %2.13%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-5.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.8
FCFYN/A
OCF(TTM)-2.8
OCFYN/A
SpS0
BVpS12.96
TBVpS11.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.38%
ROE -16.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.72%
ROA(5y)-83.68%
ROE(3y)-406.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 29.03
Quick Ratio 29.03
Altman-Z 23.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-401.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-295.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.77%
OCF growth 3YN/A
OCF growth 5YN/A

POLYRIZON LTD / PLRZ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for POLYRIZON LTD?

ChartMill assigns a fundamental rating of 3 / 10 to PLRZ.


What is the valuation status for PLRZ stock?

ChartMill assigns a valuation rating of 0 / 10 to POLYRIZON LTD (PLRZ). This can be considered as Overvalued.


What is the profitability of PLRZ stock?

POLYRIZON LTD (PLRZ) has a profitability rating of 1 / 10.


Can you provide the financial health for PLRZ stock?

The financial health rating of POLYRIZON LTD (PLRZ) is 8 / 10.